Literature DB >> 2528856

Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.

N T Foged1, J P Nielsen, S E Jorsal.   

Abstract

Pasteurella multocida toxin was purified by affinity chromatography and inactivated by treatment with formaldehyde before use as a single component vaccine against progressive atrophic rhinitis in pigs. Twenty pregnant gilts which were vaccinated twice before farrowing with either low or high doses of the purified toxoid, developed dose-dependent positive serum and colostrum titres to the toxin and, unlike the progeny of 10 untreated control gilts, the offspring of the vaccinated gilts also had serum titres. These titres could be measured in blood samples taken for more than eight weeks from birth for most pigs born to gilts vaccinated with low doses and more than 12 weeks for pigs born to gilts vaccinated with high doses of the vaccine. All the piglets were inoculated intranasally with Bordetella bronchiseptica and toxigenic P multocida. The clinical and post mortem examinations of snouts revealed a significant reduction in the frequency and degree of conchal atrophy in the two groups of pigs from the vaccinated gilts compared with the pigs from control gilts. Clinically 90 per cent of the snouts of pigs born to vaccinated gilts appeared normal whereas only 28 per cent of the snouts of control pigs were not shortened or deviated at eight weeks of age. At slaughter 11 per cent of the pigs born to vaccinated gilts and 81 per cent of the control pigs had severe turbinate atrophy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2528856     DOI: 10.1136/vr.125.1.7

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  12 in total

1.  Antibody response in sows and piglets following vaccination against Mycoplasma hyopneumoniae, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae.

Authors:  Charlotte S Kristensen; Margit Andreasen; Annette K Ersbøll; Jens P Nielsen
Journal:  Can J Vet Res       Date:  2004-01       Impact factor: 1.310

Review 2.  Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

Review 3.  Pasteurella multocida toxin interaction with host cells: entry and cellular effects.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Effect of aerial ammonia on porcine infection of the respiratory tract with toxigenic Pasteurella multocida.

Authors:  M Andreasen; P Baekbo; J P Nielsen
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

5.  The pnhA gene of Pasteurella multocida encodes a dinucleoside oligophosphate pyrophosphatase member of the Nudix hydrolase superfamily.

Authors:  Tonia Urick; Chien I-Chang; Ellen Arena; Wenlian Xu; Maurice J Bessman; Carmel G Ruffolo
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

6.  Signature-tagged mutagenesis of Pasteurella multocida identifies mutants displaying differential virulence characteristics in mice and chickens.

Authors:  Marina Harper; John D Boyce; Ian W Wilkie; Ben Adler
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  The outer membrane of Pasteurella multocida 3:A protects rabbits against homologous challenge.

Authors:  Y S Lu; W C Lai; S P Pakes; C Stefanu
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Protective immunity conferred by the C-terminal fragment of recombinant Pasteurella multocida toxin.

Authors:  Jeongmin Lee; Hae-Eun Kang; Hee-Jong Woo
Journal:  Clin Vaccine Immunol       Date:  2012-07-25

9.  Experimental model of atrophic rhinitis in gnotobiotic pigs.

Authors:  M R Ackermann; R B Rimler; J R Thurston
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  A heptosyltransferase mutant of Pasteurella multocida produces a truncated lipopolysaccharide structure and is attenuated in virulence.

Authors:  Marina Harper; Andrew D Cox; Frank St Michael; Ian W Wilkie; John D Boyce; Ben Adler
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.